Skip to Content
Merck

The dTAG system for immediate and target-specific protein degradation.

Nature chemical biology (2018-03-28)
Behnam Nabet, Justin M Roberts, Dennis L Buckley, Joshiawa Paulk, Shiva Dastjerdi, Annan Yang, Alan L Leggett, Michael A Erb, Matthew A Lawlor, Amanda Souza, Thomas G Scott, Sarah Vittori, Jennifer A Perry, Jun Qi, Georg E Winter, Kwok-Kin Wong, Nathanael S Gray, James E Bradner
ABSTRACT

Dissection of complex biological systems requires target-specific control of the function or abundance of proteins. Genetic perturbations are limited by off-target effects, multicomponent complexity, and irreversibility. Most limiting is the requisite delay between modulation to experimental measurement. To enable the immediate and selective control of single protein abundance, we created a chemical biology system that leverages the potency of cell-permeable heterobifunctional degraders. The dTAG system pairs a novel degrader of FKBP12F36V with expression of FKBP12F36V in-frame with a protein of interest. By transgene expression or CRISPR-mediated locus-specific knock-in, we exemplify a generalizable strategy to study the immediate consequence of protein loss. Using dTAG, we observe an unexpected superior antiproliferative effect of pan-BET bromodomain degradation over selective BRD4 degradation, characterize immediate effects of KRASG12V loss on proteomic signaling, and demonstrate rapid degradation in vivo. This technology platform will confer kinetic resolution to biological investigation and provide target validation in the context of drug discovery.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
dTAG-13, ≥98% (HPLC)
Sigma-Aldrich
Biotin-Thalidomide, ≥95%
Sigma-Aldrich
Biotin-SLF
Sigma-Aldrich
Anti-Glyceraldehyde-3-Phosphate Dehydrogenase Antibody, clone 6C5, clone 6C5, Chemicon®, from mouse
Sigma-Aldrich
dBET6, ≥98% (HPLC)